FDA Implemented Strictness in the Drug Approval For 2009

FDA the food and Drugs administration has been seen working on the strict rules for the implementation of security measures for the manufacturers of drugs. The news media have reported that very few drugs have been approved by FDA in the last year and some lucky among them were Novartis’ kidney cancer drug Afinitor and Bausch and Lomb’s pink eye medicine Besivance.

Photo by matchbookromancebang

This might be because of the fact that President Barack Obama tapped Commissioner Margaret Hamburg and Deputy Commissioner Joshua Sharfstein in the last year to restore the credibility of the agency by influencing mainly on the safety of drugs and than in August last year Hamburg announced that the agency would speed up and expand its issuance of warning letters to the companies that don’t follow FDA regulations.

The result of these announcements as stated before has been seen as the few approving letter for the drugs manufacturers and this has also annoyed the drug industry and their executives have criticized FDA for taking such actions. Many people even say that the agency has become over conscious on the matters of safety but overall it looks like a very good decision which will ensure best effects for the patients.